New Predictive CardioGenomic™ Profile Test

Share Article

Natures Intentions Naturopathic Clinic offers new predictive genomic test -- provides basis for customized treatments designed to prevent cardiovascular disease.

Natures Intentions Naturopathic Clinic is pleased to announce the latest clinical tool in the new era of genomics-based, personalized health care. Our medical practice is now offering the CardioGenomic™ Profile, developed by Genovations,™ to identify patients who may be more genetically susceptible to developing heart disease, stroke, and other cardiovascular-related health problems.

Using a single blood or mouth rinse sample, this advanced test evaluates genetic variations, called single nucleotide polymorphisms (SNPs), that help reveal how each person’s body is genetically “wired” to break down and clear dietary fats, metabolize cholesterol, activate blood clots, and regulate blood pressure. The SNPs do not cause cardiovascular disease by themselves, but indicate the potential for increased risk when they interact with environmental, dietary, and lifestyle factors. By modifying these factors, an individual may potentially reduce his or her cardiovascular risk significantly.

For example, the test can identify individuals who may have higher risk of developing a blood clot while taking birth control pills or hormone replacement therapy. In addition, the test may help identify those more likely to develop high cholesterol in response to dietary fat, or high blood pressure in response to high salt intake. It also evaluates genetic markers linked to chronic inflammation, which is increasingly recognized by health experts as a major contributor to cardiovascular disease.

“This new test will allow patients to uncover potential ‘vulnerable’ spots in their genetic blueprint, giving them the unprecedented opportunity to adopt a more effective, personalized prevention program against cardiovascular disease before it has a chance to develop,” explains Patrick Hanaway, M.D., Medical Director of Genovations.™

According to the American Heart Association, cardiovascular disease is still the leading cause of mortality in the U.S., causing four out of every ten deaths. About 62 million Americans are estimated to have some form of cardiovascular disease.

Individuals with a personal or family history of high blood pressure (hypertension), high cholesterol, heart disease, stroke, chronic obesity, or blood clots (thromboses), are primary candidates for the new test. And because nearly 50% of all heart attacks strike people with normal cholesterol levels, even seemingly healthy individuals can also benefit from the test, by using the results to reduce “hidden” cardiovascular risks they may not be aware of.

If you want to learn more about the new CardioGenomic™ Profile and how it can provide the basis for more effective, personalized health care to prevent cardiovascular disease, call Natures Intentions Naturopathic Clinic for more information.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author